Holen Sie sich die Stockscreener-App
79.14
1.28%
0.93
Schlusskurs vom Vortag:
$78.21
Offen:
$79
24-Stunden-Volumen:
23,995
Relative Volume:
0.05
Marktkapitalisierung:
$3.36B
Einnahmen:
$17.39M
Nettoeinkommen (Verlust:
$-135.89M
KGV:
-17.06
EPS:
-4.64
Netto-Cashflow:
$-123.00M
1W Leistung:
-1.93%
1M Leistung:
-0.43%
6M Leistung:
+91.84%
1J Leistung:
+43.39%
1-Tages-Spanne:
$76.61
$80.03
1-Wochen-Bereich:
$76.34
$82.31
52-Wochen-Spanne:
$38.51
$85.25
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
Firmenname
Tarsus Pharmaceuticals Inc
Sektor
Branche
Telefon
(949) 409-9820
Adresse
15440 LAGUNA CANYON ROAD, IRVINE
Vergleichen Sie TARS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
79.11 | 3.32B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.17 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
811.91 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
815.66 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.96 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-20 | Eingeleitet | Mizuho | Outperform |
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-11-20 | Eingeleitet | Goldman | Neutral |
| 2023-07-18 | Eingeleitet | William Blair | Outperform |
| 2023-05-18 | Eingeleitet | Guggenheim | Buy |
| 2022-08-01 | Eingeleitet | Barclays | Overweight |
| 2021-12-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-23 | Eingeleitet | Oppenheimer | Outperform |
| 2020-11-10 | Eingeleitet | BofA Securities | Buy |
| 2020-11-10 | Eingeleitet | Jefferies | Buy |
| 2020-11-10 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-11-10 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Tarsus Pharmaceuticals Inc Aktie (TARS) Neueste Nachrichten
What analyst consensus says on Tarsus Pharmaceuticals Inc. stockStop Loss & Smart Allocation Stock Tips - ulpravda.ru
Why Tarsus Pharmaceuticals Inc. stock is trending among retail tradersPortfolio Value Report & Real-Time Stock Entry Alerts - ulpravda.ru
Growth Recap: Why Tarsus Pharmaceuticals Inc. stock is trending among retail tradersMarket Activity Summary & Free Long-Term Investment Growth Plans - ulpravda.ru
Will Tarsus Pharmaceuticals Inc. stock outperform tech sector in 2025Portfolio Gains Summary & Free Real-Time Volume Trigger Notifications - ulpravda.ru
Insider Sell Alert: Dianne Whitfield Sells 15,565 Shares of Tarsus Pharmaceuticals Inc (TARS) - GuruFocus
Avoiding Lag: Real-Time Signals in (TARS) Movement - Stock Traders Daily
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) CEO Bobak Azamian Sells 6,000 Shares - MarketBeat
Tarsus Pharmaceuticals Insider Sold Shares Worth $495,089, According to a Recent SEC Filing - MarketScreener
Will Tarsus Pharmaceuticals Inc. stock split attract more investorsDividend Cut Warnings & Low Risk Investment Plans - bollywoodhelpline.com
Tarsus to Participate at the Bank of America 2023 Healthcare Conference - 富途牛牛
240,020 Shares in Tarsus Pharmaceuticals, Inc. $TARS Purchased by Capricorn Fund Managers Ltd - MarketBeat
Tarsus Pharmaceuticals Earnings Notes - Trefis
Market Sentiment Around Loss-Making Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - simplywall.st
Will Tarsus Pharmaceuticals Inc. stock see PE expansionTake Profit Strategies & Free Hedging Tactics for Volatile Markets - Bollywood Helpline
Tarsus Pharmaceuticals (TARS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Technical Reactions to TARS Trends in Macro Strategies - Stock Traders Daily
Why Tarsus Pharmaceuticals Inc. stock could rally in 2025July 2025 Opening Moves & Weekly Breakout Watchlists - Улправда
Can Tarsus Pharmaceuticals Inc. stock double in next 5 yearsJuly 2025 Retail & AI Enhanced Trading Signals - Улправда
Can Tarsus Pharmaceuticals Inc. stock hit record highs againJuly 2025 Trade Ideas & AI Driven Price Predictions - DonanımHaber
Why analysts upgrade Tarsus Pharmaceuticals Inc. stock2025 Technical Overview & Fast Gaining Stock Reports - Улправда
Insider Sell: Dianne Whitfield Sells 7,397 Shares of Tarsus Phar - GuruFocus
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Dianne Whitfield Sells 7,397 Shares - MarketBeat
Tarsus Pharmaceuticals Insider Sold Shares Worth $592,500, According to a Recent SEC Filing - marketscreener.com
Tarsus Pharmaceuticals (TARS) COO discloses stock gifts and 79,183-share stake - Stock Titan
Assenagon Asset Management S.A. Has $74.17 Million Stock Holdings in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Officer Whitfield Files To Sell 7,397 Of Tarsus Pharmaceuticals Inc [TARS] - TradingView — Track All Markets
Squarepoint Ops LLC Boosts Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
TFG Asset Management GP Ltd Grows Stake in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Trading the Move, Not the Narrative: (TARS) Edition - Stock Traders Daily
Tarsus Pharmaceuticals (NASDAQ:TARS) Upgraded at Barclays - MarketBeat
Tarsus Pharmaceuticals chief medical officer talks AI in eye care - Healthcare Brew
Barclays Initiates Coverage on Tarsus Pharmaceuticals (TARS) wit - GuruFocus
Jump Financial LLC Purchases 188,317 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Norges Bank Acquires Shares of 471,354 Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 12-Month HighHere's What Happened - MarketBeat
Tarsus Pharmaceuticals stock hits all-time high at 83.67 USD - Investing.com
Tarsus Pharmaceuticals stock hits all-time high at 83.67 USD By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals Leads Six-Month Stock Performance with 85.5% Return - Markets Mojo
Quantbot Technologies LP Purchases 24,319 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Can Tarsus Pharmaceuticals Stock Still Offer Value After Its 48% 2025 Rally? - Yahoo Finance
Tarsus Pharmaceuticals (TARS): Revisiting Valuation After a Strong Multi‑Year Share Price Run - Sahm
Quadrature Capital Ltd Invests $588,000 in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
(TARS) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Virtus Investment Advisers LLC Buys 3,827 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals, Inc. $TARS Shares Bought by Prudential Financial Inc. - MarketBeat
Geode Capital Management LLC Raises Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Magnetar Financial LLC Takes $596,000 Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Hits New 1-Year HighHere's What Happened - MarketBeat
Tarsus to Participate in Upcoming Investor Conference - The Manila Times
Finanzdaten der Tarsus Pharmaceuticals Inc-Aktie (TARS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):